After analyzing the database with pathogenic mutations most frequently identified in BRCA genes and excluding studies with overlapping samples, we can verify that the c.5266dupC mutation in BRCA1 is the most commonly found in Brazil in patients with breast and/or ovarian cancer. The gene discussed is BRCA1; the disease is ovarian cancer.